NAD+ 60mg — Vial Spec, Reconstitution Math & COA

Overview of NAD+ 60mg Research Vials

A 60mg vial of NAD+ contains highly purified, lyophilized Nicotinamide Adenine Dinucleotide powder engineered for controlled laboratory environments. This specific mass standard provides researchers with sufficient active material to execute multi-well enzymatic assays, cell culture interventions, or longitudinal metabolic studies without requiring frequent re-solubilization of smaller unit sizes. Institutional investigators typically order 60mg units when establishing standardized stock solutions for high-density screening or running concurrent microplate series.

While specific bulk configurations like 60mg may be prepared for specialized lab accounts or custom research orders, primary standard catalog offerings can be reviewed on our main NAD+ product page. Researchers seeking alternative unit masses or complementary reagents can explore the full catalog via our research peptide directory. All unit sizes supplied by PX1 Research undergo identical analytical verification protocols to guarantee baseline identity, mass accuracy, and chemical purity.

Molecular Identity and Enzymatic Targets in Preclinical Studies

Nicotinamide Adenine Dinucleotide (CAS 53-84-9, molecular weight 663.43 g/mol) is a essential dinucleotide coenzyme present in all living cells. Chemically composed of two nucleotides joined through their phosphate groups—one containing an adenine base and the other nicotinamide—NAD+ exists in both an oxidized form (NAD+) and a reduced form (NADH). Preclinical literature establishes NAD+ as a mandatory electron acceptor in glycolysis and the tricarboxylic acid (TCA) cycle, as well as a critical co-substrate for enzymes regulating genomic stability and cellular stress responses.

In vitro models primarily utilize NAD+ to investigate the enzymatic kinetics of sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (such as CD38 and CD157). Because NAD+ is consumed as a co-substrate during deacetylation and ADP-ribosyltransferase reactions, maintaining accurate bath concentrations in cell-free or cell-culture models is essential for quantitative biochemical analysis.

Reconstitution Mathematics for 60mg NAD+ Vials

Accurate volumetric reconstitution is paramount when preparing 60mg lyophilized NAD+ for quantitative analytical protocols. Depending on the desired final working concentration, laboratory personnel must calculate the exact solvent volume required. Diluent selection generally depends on downstream assay compatibility, with bacteriostatic water, sterile normal saline, or phosphate-buffered saline (PBS) being common vehicles.

To achieve target concentrations from a 60mg vial, apply the following volumetric calculations: • 1.0 mL Diluent Addition: Yields a stock concentration of 60.0 mg/mL (60.0 µg/µL or approximately 90.44 mM). • 2.0 mL Diluent Addition: Yields a stock concentration of 30.0 mg/mL (30.0 µg/µL or approximately 45.22 mM). • 3.0 mL Diluent Addition: Yields a stock concentration of 20.0 mg/mL (20.0 µg/µL or approximately 30.15 mM). • 6.0 mL Diluent Addition: Yields a stock concentration of 10.0 mg/mL (10.0 µg/µL or approximately 15.07 mM).

For complex dilutions or custom assay molarities, researchers are encouraged to utilize our automated peptide reconstitution calculator to prevent mathematical errors in experimental prep.

Aliquot Planning and Buffer Compatibility

Reconstituting a 60mg vial into a single concentrated stock solution requires an aliquot strategy to maintain molecular stability over extended experimental timelines. Repeated freeze-thaw cycles accelerate the non-enzymatic hydrolysis of NAD+ into nicotinamide and ADP-ribose, which alters baseline experimental conditions and introduces confounding metabolic byproducts into culture media.

Upon full dissolution, the primary solution should be divided under sterile conditions into single-use microcentrifuge tubes (e.g., 50 µL to 200 µL aliquots) depending on daily protocol demands. When using buffered media such as PBS, researchers must verify that the pH remains strictly between 6.5 and 7.5; aqueous NAD+ exhibits enhanced degradation kinetics in strongly alkaline environments.

Thermal Stability and Long-Term Laboratory Storage

Unreconstituted, lyophilized NAD+ 60mg vials must be stored at -20°C for short-to-medium term storage, or at -80°C for long-term archival preservation. Under proper desiccation and sub-zero storage, the chemical structure remains stable against auto-oxidation. Laboratory environments should minimize ambient light exposure, as NAD+ is sensitive to UV-induced degradation over extended durations.

Once solubilized, reconstituted stock aliquots should be frozen immediately at -80°C. Working solutions maintained at 4°C should be utilized within 24 to 48 hours to prevent enzymatic degradation or chemical breakdown. Solubilized material must never be kept at room temperature for prolonged periods prior to assay execution.

Analytical Verification: Lot-Matched COA and Quality Control

PX1 Research enforces strict quality control standards for every manufacturing lot. Each batch of NAD+ is synthesized in GMP-compliant facilities within the USA and subjected to comprehensive analytical verification in an independent ISO 17025 accredited laboratory.

Quality assurance includes High-Performance Liquid Chromatography (HPLC) to verify chemical purity (>98%), Mass Spectrometry (MS) to confirm exact molecular weight and structural identity, and Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels suitable for sensitive biological systems. Researchers can review or download lot-specific documentation directly from our dedicated certificate of analysis hub. All orders ship directly from our centralized warehouses in California and Arizona, with same-day dispatch available Monday through Friday.

Comparative Analysis: NAD+ and Related Metabolic Compounds

In mitochondrial and bioenergetic research, investigators frequently evaluate NAD+ alongside complementary precursor molecules and signaling peptides to map pathway kinetics. For instance, direct administration of /product/nmn (Nicotinamide Mononucleotide) is often studied in parallel with NAD+ to assess intracellular uptake transport mechanisms versus extracellular conversion rates. In mitochondrial dynamics research, compounds such as /research-peptides/motc-5mg (MOTS-c) target nuclear gene expression related to metabolic homeostasis, while /product/ss-31 (Elamipretide) selectively binds to cardiolipin in the inner mitochondrial membrane to optimize electron transport chain efficiency without altering total dinucleotide pool sizes.

The following matrix summarizes key structural and functional parameters of these research compounds:

Determining Optimal Mass Formats for Laboratory Workflows

Selecting between a 60mg mass standard and alternative vial capacities depends primarily on experimental scale, automation equipment, and sample size. Small-scale in vitro preliminary trials often utilize smaller vial sizes to avoid holding excess reconstituted stock in storage. Conversely, high-throughput screening assays—such as automated 384-well plate enzymatic panels—require larger unified lots like 60mg to maintain uniform concentration across all experimental replicates.

For institutional laboratories conducting large-scale preclinical studies or multi-center research, standardized volume procurement minimizes batch-to-batch variation across extended research timelines. Lab directors and procurement managers seeking custom unit allocations or volume pricing can explore options through our dedicated wholesale laboratory portal.

Methodological Considerations for In Vitro Assay Design

When integrating NAD+ into cell-based assays or cell-free enzymatic reactions, researchers must account for baseline intracellular concentrations and extracellular degradation enzymes. In vitro cell cultures often express cell-surface hydrolases (such as CD38) that break down extracellular NAD+ into NMN and adenosine. Control groups should be designed to differentiate between direct intracellular coenzyme utilization and extracellular cleavage pathways.

Furthermore, fluorometric and spectrophotometric assays relying on NADH absorbance at 340 nm require baseline control calibration to subtract background auto-fluorescence. Additional technical resources, biochemical pathways, and trial methodologies are documented within the PX1 research library hub.